Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADROPARIN: 676 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
676
Total FAERS Reports
57 (8.4%)
Deaths Reported
355
Hospitalizations
676
As Primary/Secondary Suspect
64
Life-Threatening
22
Disabilities

Active Ingredient: NADROPARIN CALCIUM ·

First Report: 20010226 · Latest Report: 20250509

What Are the Most Common NADROPARIN Side Effects?

#1 Most Reported
Foetal exposure during pregnancy
81 reports (12.0%)
#2 Most Reported
Off label use
77 reports (11.4%)
#3 Most Reported
Premature baby
73 reports (10.8%)

All NADROPARIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Foetal exposure during pregnancy 81 12.0% 5 21
Off label use 77 11.4% 17 44
Premature baby 73 10.8% 3 30
Maternal exposure during pregnancy 72 10.7% 1 25
Drug ineffective 54 8.0% 3 25
Sepsis 46 6.8% 0 45
Dyspnoea 44 6.5% 2 29
Fall 43 6.4% 0 42
Exposure during pregnancy 42 6.2% 0 5
Confusional state 40 5.9% 19 26
Diarrhoea 34 5.0% 0 27
Hypertension 34 5.0% 19 19
Premature delivery 34 5.0% 0 7
Thrombocytopenia 33 4.9% 4 28
Platelet count decreased 32 4.7% 0 30
Low birth weight baby 31 4.6% 3 18
Oedema peripheral 29 4.3% 0 26
Product use in unapproved indication 29 4.3% 2 21
Pulmonary embolism 27 4.0% 5 18
Condition aggravated 25 3.7% 2 13

Who Reports NADROPARIN Side Effects? Age & Gender Data

Gender: 58.5% female, 41.5% male. Average age: 56.3 years. Most reports from: IT. View detailed demographics →

Is NADROPARIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2001 15 0 15
2002 2 0 2
2006 9 0 9
2007 1 0 1
2009 1 0 0
2012 6 0 4
2013 7 1 3
2014 46 3 42
2015 30 3 23
2016 47 4 30
2017 21 2 8
2018 39 3 25
2019 40 1 23
2020 52 22 27
2021 13 0 6
2022 12 0 9
2023 16 0 1
2024 11 0 6
2025 2 0 2

View full timeline →

What Is NADROPARIN Used For?

IndicationReports
Product used for unknown indication 251
Thrombosis prophylaxis 79
Anticoagulant therapy 51
Prophylaxis 38
Covid-19 23
Deep vein thrombosis 19
Venous thrombosis limb 19
Pulmonary embolism 17
Foetal exposure during pregnancy 16
Thrombosis 15

NADROPARIN vs Alternatives: Which Is Safer?

NADROPARIN vs NAFARELIN NADROPARIN vs NAFCILLIN NADROPARIN vs NAFCILLIN\NAFCILLIN NADROPARIN vs NAFRONYL NADROPARIN vs NAFTIFINE NADROPARIN vs NAGLAZYME NADROPARIN vs NALBUPHINE NADROPARIN vs NALDEMEDINE NADROPARIN vs NALMEFENE NADROPARIN vs NALOXEGOL OXALATE

Official FDA Label for NADROPARIN

Official prescribing information from the FDA-approved drug label.